Neo-medrol Acetate


Neo-medrol Acetate

Drug - Neo-medrol Acetate
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylprednisolone Acetate; Neomycin Sulfate
Multiple ingredients are in alphabetical order.

Strength - 1%;EQ 3.5MG BASE/GM
The potency of the active ingredient(s), Methylprednisolone Acetate; Neomycin Sulfate. May repeat for multiple part products.

The firm name holding legal responsibility for Neo-medrol Acetate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 060611
The FDA assigned number to Neo-medrol Acetate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Neo-medrol Acetate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Neo-medrol Acetate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Neo-medrol Acetate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Neo-medrol Acetate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Neo-medrol Acetate.

Neo-medrol Acetate